TW216446B - - Google Patents

Info

Publication number
TW216446B
TW216446B TW080100246A TW80100246A TW216446B TW 216446 B TW216446 B TW 216446B TW 080100246 A TW080100246 A TW 080100246A TW 80100246 A TW80100246 A TW 80100246A TW 216446 B TW216446 B TW 216446B
Authority
TW
Taiwan
Application number
TW080100246A
Other languages
Chinese (zh)
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Application granted granted Critical
Publication of TW216446B publication Critical patent/TW216446B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
TW080100246A 1989-11-20 1991-01-12 TW216446B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20

Publications (1)

Publication Number Publication Date
TW216446B true TW216446B (cg-RX-API-DMAC7.html) 1993-11-21

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
TW080100246A TW216446B (cg-RX-API-DMAC7.html) 1989-11-20 1991-01-12

Country Status (14)

Country Link
EP (1) EP0502105A4 (cg-RX-API-DMAC7.html)
JP (1) JPH05503629A (cg-RX-API-DMAC7.html)
KR (1) KR920703639A (cg-RX-API-DMAC7.html)
AU (1) AU636944B2 (cg-RX-API-DMAC7.html)
CA (1) CA2068713A1 (cg-RX-API-DMAC7.html)
ES (1) ES2052478T1 (cg-RX-API-DMAC7.html)
FI (1) FI922277A0 (cg-RX-API-DMAC7.html)
GR (1) GR930300005T1 (cg-RX-API-DMAC7.html)
HU (1) HUT60506A (cg-RX-API-DMAC7.html)
NO (1) NO921969L (cg-RX-API-DMAC7.html)
OA (1) OA09698A (cg-RX-API-DMAC7.html)
TW (1) TW216446B (cg-RX-API-DMAC7.html)
WO (1) WO1991007425A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA909302B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034025B2 (ja) * 1989-06-01 2000-04-17 アプライド・バイオテクノロジー・インコーポレーテツド 自己アセンブルド欠損非自己増殖性ウイルス粒子
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
EP1136562A3 (en) * 1991-11-08 2003-06-25 PHARMACIA & UPJOHN COMPANY Feline leukemia virus vaccines
AU2462392A (en) * 1992-04-14 1993-11-18 British Biotech Pharmaceuticals Limited Induction of CTL responses
EP1770168A3 (en) * 1993-01-26 2009-05-06 The Trustees of the University of Pennsylvania (a corporation of Pennsylvania) Compositions and methods for delivery of genetic material
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
CA2153593C (en) 1993-01-26 2010-04-13 David B. Weiner Compositions and methods for delivery of genetic material
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
WO1996030523A2 (en) * 1995-03-31 1996-10-03 Hans Wolf Antigen presentation system based on retrovirus-like particles
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
WO2000039304A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
EP1141315B1 (en) 1998-12-31 2008-01-23 Novartis Vaccines and Diagnostics, Inc. Modified hiv env polypeptides
WO2002072754A2 (en) * 2001-03-08 2002-09-19 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mva expressing modified hiv envelope, gag, and pol genes
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
EP2388015A1 (en) 2000-03-02 2011-11-23 Emory University DNA expression vectors and methods of use
EP2412242A3 (en) 2001-07-05 2012-06-13 Novartis Vaccines and Diagnostics, Inc. Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP3173096A1 (en) 2011-04-06 2017-05-31 Biovaxim Limited Pharmaceutical compositions for preventing and/or treating an hiv disease in humans
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
US11752206B2 (en) 2017-03-15 2023-09-12 Modernatx, Inc. Herpes simplex virus vaccine
US11045540B2 (en) 2017-03-15 2021-06-29 Modernatx, Inc. Varicella zoster virus (VZV) vaccine
EP3938379A4 (en) * 2019-03-15 2023-02-22 ModernaTX, Inc. Hiv rna vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
CA2067778A1 (en) * 1989-10-16 1991-04-17 The Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
JPH05503629A (ja) 1993-06-17
ZA909302B (en) 1991-09-25
EP0502105A1 (en) 1992-09-09
NO921969D0 (no) 1992-05-19
AU636944B2 (en) 1993-05-13
ES2052478T1 (es) 1994-07-16
NO921969L (no) 1992-06-26
WO1991007425A1 (en) 1991-05-30
EP0502105A4 (en) 1993-02-24
AU6905591A (en) 1991-06-13
GR930300005T1 (cg-RX-API-DMAC7.html) 1993-04-28
KR920703639A (ko) 1992-12-18
CA2068713A1 (en) 1991-05-21
HUT60506A (en) 1992-09-28
FI922277A7 (fi) 1992-05-19
OA09698A (en) 1993-08-30
FI922277A0 (fi) 1992-05-19
HU9201659D0 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
TW216446B (cg-RX-API-DMAC7.html)
FR2641750B1 (cg-RX-API-DMAC7.html)
FR2641722B1 (cg-RX-API-DMAC7.html)
DE3991793T1 (cg-RX-API-DMAC7.html)
DE3991752T (cg-RX-API-DMAC7.html)
DE4092109T (cg-RX-API-DMAC7.html)
FR2654501B1 (cg-RX-API-DMAC7.html)
FR2655368B1 (cg-RX-API-DMAC7.html)
FR2642552B1 (cg-RX-API-DMAC7.html)
DE4042389A1 (cg-RX-API-DMAC7.html)
EP0668703A3 (cg-RX-API-DMAC7.html)
FR2645335B1 (cg-RX-API-DMAC7.html)
AU6779590A (cg-RX-API-DMAC7.html)
DE4092381T (cg-RX-API-DMAC7.html)
FI892768A7 (cg-RX-API-DMAC7.html)
FR2642504B3 (cg-RX-API-DMAC7.html)
FR2636293B1 (cg-RX-API-DMAC7.html)
DE3991728T (cg-RX-API-DMAC7.html)
FR2649720B1 (cg-RX-API-DMAC7.html)
FR2651072B3 (cg-RX-API-DMAC7.html)
IN173582B (cg-RX-API-DMAC7.html)
GR2000692Y (cg-RX-API-DMAC7.html)
AU2039388A (cg-RX-API-DMAC7.html)
AU1976688A (cg-RX-API-DMAC7.html)
AU2198188A (cg-RX-API-DMAC7.html)